Dedifferentiation and reprogramming: Origins of cancer stem cells

EMBO Reports

Volumn 15, Issue 3, 2014, Pages 244-253

  Friedmann Morvinski, Dinorah ^a   Verma, Inder M ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

cancer stem cells; dedifferentiation; somatic reprogramming; tumor plasticity

Indexed keywords

BREAST CARCINOMA; BREAST EPITHELIUM; CANCER GROWTH; CANCER STEM CELL; CELL DEDIFFERENTIATION; CELL TRANSDIFFERENTIATION; CHROMATIN STRUCTURE; CHROMOSOME ABERRATION; DNA METHYLATION; EMBRYONIC STEM CELL; GENETIC HETEROGENEITY; GENOMIC INSTABILITY; HUMAN; INTESTINE EPITHELIUM CELL; LIGHT CHAIN; MYOFIBROBLAST; NEURAL STEM CELL; NUCLEAR REPROGRAMMING; ONCOGENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SICKLE CELL ANEMIA; SOMATIC CELL; TISSUE REPAIR; TUMOR MICROENVIRONMENT;

ANIMALS; CARCINOGENS; CELL DEDIFFERENTIATION; CELL LINEAGE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEOPLASTIC STEM CELLS; NUCLEAR REPROGRAMMING;

EID: 84898645670     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1002/embr.201338254     Document Type: Review

References (74)

1. Kaiser LR, (1992) The future of multihospital systems. Top Health Care Financ 18: 32-45
2. Lysaght MJ, Crager J, (2009) Origins. Tissue Eng Part A 15: 1449-1450
3. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676 (Pubitemid 44233629)
4. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, et al, (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920
5. Briggs R, King TJ, (1952) Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc Natl Acad Sci USA 38: 455-463
6. Gurdon JB, (1962) The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 10: 622-640
7. Sommer CA, Mostoslavsky G, (2013) The evolving field of induced pluripotency: recent progress and future challenges. J Cell Physiol 228: 267-275
8. Malik N, Rao MS, (2013) A review of the methods for human iPSC derivation. Methods Mol Biol 997: 23-33
9. Gonzalez F, Boue S, Izpisua Belmonte JC, (2011) Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet 12: 231-242
10. Orkin SH, Hochedlinger K, (2011) Chromatin connections to pluripotency and cellular reprogramming. Cell 145: 835-850
11. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A, (2008) Dissecting direct reprogramming through integrative genomic analysis. Nature 454: 49-55 (Pubitemid 351931978)
12. Koche RP, Smith ZD, Adli M, Gu H, Ku M, Gnirke A, Bernstein BE, Meissner A, (2011) Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 8: 96-105
13. Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, Brooks M, Reinhardt F, Su Y, Polyak K, et al, (2011) Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA 108: 7950-7955
14. Roy S, Gascard P, Dumont N, Zhao J, Pan D, Petrie S, Margeta M, Tlsty TD, (2013) Rare somatic cells from human breast tissue exhibit extensive lineage plasticity. Proc Natl Acad Sci USA 110: 4598-4603
15. Tata PR, Mou H, Pardo-Saganta A, Zhao R, Prabhu M, Law BM, Vinarsky V, Cho JL, Breton S, Sahay A, et al, (2013) Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature 503: 218-223
16. van Es JH, Sato T, van de Wetering M, Lyubimova A, Nee AN, Gregorieff A, Sasaki N, Zeinstra L, van den Born M, Korving J, et al, (2012) Dll1 + secretory progenitor cells revert to stem cells upon crypt damage. Nat Cell Biol 14: 1099-1104
17. Visvader JE, Lindeman GJ, (2012) Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10: 717-728
18. Visvader JE, (2011) Cells of origin in cancer. Nature 469: 314-322
19. Bachoo RM, Maher EA, Ligon KL, Sharpless NE, Chan SS, You MJ, Tang Y, DeFrances J, Stover E, Weissleder R, et al, (2002) Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1: 269-277 (Pubitemid 41039151)
20. Friedmann-Morvinski D, Bushong EA, Ke E, Soda Y, Marumoto T, Singer O, Ellisman MH, Verma IM, (2012) Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science 338: 1080-1084
21. Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, Michiue H, Pastorino S, Yang M, Hoffman RM, Kesari S, et al, (2011) Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA 108: 4274-4280
22. Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T, Goktuna SI, Ziegler PK, Canli O, Heijmans J, Huels DJ, Moreaux G, et al, (2013) Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152: 25-38
23. Karin M, Greten FR, (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759 (Pubitemid 41400849)
24. Gupta PB, Chaffer CL, Weinberg RA, (2009) Cancer stem cells: mirage or reality? Nat Med 15: 1010-1012
25. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al, (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715 (Pubitemid 351636299)
26. Chaffer CL, Marjanovic ND, Lee T, Bell G, Kleer CG, Reinhardt F, D'Alessio AC, Young RA, Weinberg RA, (2013) Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154: 61-74
27. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890
28. Ischenko I, Zhi J, Moll UM, Nemajerova A, Petrenko O, (2013) Direct reprogramming by oncogenic Ras and Myc. Proc Natl Acad Sci USA 110: 3937-3942
29. Guerra C, Schuhmacher AJ, Canamero M, Grippo PJ, Verdaguer L, Perez-Gallego L, Dubus P, Sandgren EP, Barbacid M, (2007) Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11: 291-302 (Pubitemid 46349841)
30. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA, (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507 (Pubitemid 351601215)
31. Gidekel Friedlander SY, Chu GC, Snyder EL, Girnius N, Dibelius G, Crowley D, Vasile E, DePinho RA, Jacks T, (2009) Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 16: 379-389
32. Anokye-Danso F, Trivedi CM, Juhr D, Gupta M, Cui Z, Tian Y, Zhang Y, Yang W, Gruber PJ, Epstein JA, et al, (2011) Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8: 376-388
33. Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, et al, (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12: 468-476
34. Landsberg J, Kohlmeyer J, Renn M, Bald T, Rogava M, Cron M, Fatho M, Lennerz V, Wolfel T, Holzel M, et al, (2012) Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 490: 412-416
35. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT, (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8: 610-622 (Pubitemid 47093931)
36. Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Dowell JM, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Wagner M, et al, (2007) Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 13: 1253-1259 (Pubitemid 46424067)
37. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, et al, (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468: 824-828
38. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C, Tabar V, (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468: 829-833
39. Cheng L, Huang Z, Zhou W, Wu Q, Donnola S, Liu JK, Fang X, Sloan AE, Mao Y, Lathia JD, et al, (2013) Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 153: 139-152
40. Wurmser AE, Nakashima K, Summers RG, Toni N, D'Amour KA, Lie DC, Gage FH, (2004) Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 430: 350-356 (Pubitemid 38937742)
41. Gidekel S, Pizov G, Bergman Y, Pikarsky E, (2003) Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4: 361-370 (Pubitemid 37491097)
42. Madjd Z, Hashemi F, Shayanfar N, Farahani E, Zarnani A, Shrifi A, Akbari M, (2009) OCT-4, embryonic Stem cell marker expressed in breast, brain and thyroid carcinomas compared to testicular carcinoma. Iran J Cancer Prev 2: 167-173
43. Zhou X, Huang GR, Hu P, (2011) Over-expression of Oct4 in human esophageal squamous cell carcinoma. Mol Cells 32: 39-45
44. de Resende MF, Chinen LT, Vieira S, Jampietro J, da Fonseca FP, Vassallo J, Campos LC, Guimaraes GC, Soares FA, Rocha RM, (2013) Prognostication of OCT4 isoform expression in prostate cancer. Tumour Biol 34: 2665-2673
45. Hochedlinger K, Yamada Y, Beard C, Jaenisch R, (2005) Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121: 465-477 (Pubitemid 40692305)
46. Riggi N, Suva ML, De Vito C, Provero P, Stehle JC, Baumer K, Cironi L, Janiszewska M, Petricevic T, Suva D, et al, (2010) EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev 24: 916-932
47. Sarkar A, Hochedlinger K, (2013) The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell 12: 15-30
48. Yamanaka S, (2012) Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10: 678-684
49. Dang CV, (2012) MYC on the path to cancer. Cell 149: 22-35
50. Morris SA, Daley GQ, (2013) A blueprint for engineering cell fate: current technologies to reprogram cell identity. Cell Res 23: 33-48
51. Daley GQ, (2008) Common themes of dedifferentiation in somatic cell reprogramming and cancer. Cold Spring Harb Symp Quant Biol 73: 171-174
52. Baylin SB, Jones PA, (2011) A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer 11: 726-734
53. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K, (2008) Induced pluripotent stem cells generated without viral integration. Science 322: 945-949
54. Gao Y, Chen J, Li K, Wu T, Huang B, Liu W, Kou X, Zhang Y, Huang H, Jiang Y, et al, (2013) Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell 12: 453-469
55. Linhart HG, Lin H, Yamada Y, Moran E, Steine EJ, Gokhale S, Lo G, Cantu E, Ehrich M, He T, et al, (2007) Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev 21: 3110-3122 (Pubitemid 350223528)
56. Onder TT, Kara N, Cherry A, Sinha AU, Zhu N, Bernt KM, Cahan P, Marcarci BO, Unternaehrer J, Gupta PB, et al, (2012) Chromatin-modifying enzymes as modulators of reprogramming. Nature 483: 598-602
57. Chen J, Liu H, Liu J, Qi J, Wei B, Yang J, Liang H, Chen Y, Wu Y, Guo L, et al, (2013) H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet 45: 34-42
58. Shinkai Y, Tachibana M, (2011) H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev 25: 781-788
59. Lakshmikuttyamma A, Scott SA, DeCoteau JF, Geyer CR, (2010) Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition. Oncogene 29: 576-588
60. Suva ML, Riggi N, Bernstein BE, (2013) Epigenetic reprogramming in cancer. Science 339: 1567-1570
61. Zhu Q, Pao GM, Huynh AM, Suh H, Tonnu N, Nederlof PM, Gage FH, Verma IM, (2011) BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 477: 179-184
62. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, et al, (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923
63. Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, Serrano M, Blasco MA, (2009) Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4: 141-154
64. Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, Oakley DH, et al, (2011) Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144: 439-452
65. Guenther MG, Frampton GM, Soldner F, Hockemeyer D, Mitalipova M, Jaenisch R, Young RA, (2010) Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7: 249-257
66. Newman AM, Cooper JB, (2010) Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7: 258-262
67. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, et al, (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5: 111-123
68. Marchetto MC, Yeo GW, Kainohana O, Marsala M, Gage FH, Muotri AR, (2009) Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS ONE 4: e7076
69. Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, Wu JC, (2010) Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS ONE 5: e8975
70. Ohi Y, Qin H, Hong C, Blouin L, Polo JM, Guo T, Qi Z, Downey SL, Manos PD, Rossi DJ, et al, (2011) Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol 13: 541-549
71. Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, Antosiewicz-Bourget J, Egli D, Maherali N, Park IH, Yu J, et al, (2009) Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 27: 353-360
72. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, et al, (2011) Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471: 68-73
73. Asciutti S, Akiri G, Grumolato L, Vijayakumar S, Aaronson SA, (2011) Diverse mechanisms of Wnt activation and effects of pathway inhibition on proliferation of human gastric carcinoma cells. Oncogene 30: 956-966
74. Koyanagi-Aoi M, Ohnuki M, Takahashi K, Okita K, Noma H, Sawamura Y, Teramoto I, Narita M, Sato Y, Ichisaka T, et al, (2013) Differentiation- defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc Natl Acad Sci USA 110: 20569-20574